FONR

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Fonar Corp. (FONR) on Monday reported earnings of $1.6 million in its fiscal third quarter. The Melville, New York-based company said it had profit of 24 cents per share. The MRI scanner designer posted revenue of $26.5 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FONR at https://www.zacks.com/ap/FONR

Net Income decreased 25% to $2.3 million for the quarter ended March 31, 2026 as compared to the quarter ended March 31, 2025. Income from Operations for the quarter ended March 31, 2026 decreased 33% to $2.4 million as compared to the quarter ended March 31, 2025. Diluted Net Income Per Common Share Available to Common Stockholders decreased 35% to $0.24 per share for the quarter ended March 31, 2026 as compared to the quarter ended March 31, 2025. Total Revenues-Net decreased 3% to $26.5 million for the quarter ended March 31, 2026 as compared to the quarter ended March 31, 2025. Total Cash, Cash Equivalents and Short-Term Investments decreased 4% to $53.8 million at March 31, 2026 as compared to June 30, 2025. Melville, New York--(Newsfile Corp. - May 11, 2026) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported today its financial results for the 3rd quarter of fiscal 2026 and the nine-month period ended March 31, 2026. FONAR's primary source of income and growth is attributable to its diagnostic imaging management subsidiary, Health Management Company of America (HMCA). In 2009, HMCA managed 9 MRI scanners. Currently, HMCA manages 45 MRI scanners. Operating Results Total Revenues-Net for the quarter ended March 31, 2026 decreased 3% to $26.5 million as compared to $27.2 million for the quarter ended March 31, 2025. Total Revenues-Net for the nine-month period ended March 31, 2026 was $78.1 million as compared to $77.1 million for the nine-month period ended March 31, 2025. Selling, general & administrative costs (SG&A) increased 5% to $8.4 million for the quarter ended March 31, 2026 as compared to $8.0 million for the quarter ended March 31, 2025. SG&A increased 7% to $21.4 million for the nine-month period ended March 31, 2026 as compared to $20.1 million for the nine-month period ended March 31, 2025. Total Costs and Expenses were $24.0 million for the quarter ended March 31, 2026 and $23.5 million for the quarter ended March 31, 2025. Total Costs and Expenses for the nine-month period ended March 31, 2026 were $69.4 million compared to the nine-month period ended March 31, 2025 of $66.4 million. Income From Operations for the quarter ended March 31, 2026 decreased 33% to $2.4 million as compared to $3.7 million for the quarter ended March 31, 2025. Income From Operations for the nine-month period ended March 31, 2026 decreased...

Cash and cash equivalents decreased 6% to $53.0 million at December 31, 2025, as compared to $56.3 million for the fiscal year-ended June 30, 2025. Total Revenues - Net increased by 2% to $25.5 million for the quarter ended December 31, 2025, versus the corresponding quarter one year earlier. Total Revenues - Net increased by 3% to $51.6 million for the six-month period ended December 31, 2025, versus the corresponding six-month period one year earlier. Net Income increased 15% to $2.5 million for the quarter ended December 31, 2025, versus the corresponding quarter one year earlier. Net Income decreased by 16% to $5.2 million for the six-month period ended December 31, 2025, versus the corresponding six-month period one year earlier. Diluted Net Income per Common Share increased 7% to $0.31 for the quarter ended December 31, 2025, versus the corresponding quarter one year earlier. Diluted Net Income per Common Share decreased 11% to $0.66 for the six-month period ended December 31, 2025, versus the corresponding six-month period one year earlier. On December 29, 2025, the Company announced that a definitive merger agreement for the previously announced "Take Private" offer was signed. The agreement included an increase per common share of $19.00 per common share in cash, from the price previously offered in July of 2025 of $17.25 per common share. Melville, New York--(Newsfile Corp. - February 13, 2026) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported today its financial results for the second quarter of fiscal 2026 which ended December 31, 2025. FONAR's primary source of income is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA). In 2009, HMCA managed 9 MRI scanners. Currently, HMCA manages 45 MRI scanners in New York and in Florida. Financial Results Income Statement Items Total Revenues-Net for the quarter ended December 31, 2025, increased 2% to $25.5 million, as compared to $25.0 million for the corresponding quarter ended December 31, 2024. Total Revenues-Net for the six-month period ended December 31, 2025, increased 3% to $51.6 million, as compared to $50.0 million for the corresponding six-month period ended December 31, 2024. Income from Operations for the quarter ended December 31, 2025, increased 23% to $3.0 million as compared to $2.4 million for the...

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Fonar Corp. (FONR) on Friday reported earnings of $2.1 million in its fiscal second quarter. On a per-share basis, the Melville, New York-based company said it had net income of 31 cents. The MRI scanner designer posted revenue of $25.5 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FONR at https://www.zacks.com/ap/FONR

Shares of FONAR Corporation FONR have gained 0.2% since the company reported its earnings for the quarter ended Sept. 30, 2025, compared with the S&P 500 Index’s 1.9% advance over the same period. Over the past month, the stock has plunged 6.2%, while the S&P 500 has risen 3%. FONAR’s first-quarter fiscal 2026 results showed modest top-line growth but weaker profitability compared with the year-ago period. Total revenues increased 4.3% to $26 million from $24.9 million a year earlier, driven largely by continued expansion in the company’s Health Management Company of America (“HMCA”) subsidiary. However, higher operating expenses weighed on earnings. Income from operations fell 30.7% to $3.2 million from $4.6 million, and consolidated net income was down 33.3% to $2.7 million from $4 million. Diluted net income per common share declined 26.1% to $0.34 from $0.46. Segmentally, the FONAR equipment and service division posted a 17.9% revenue increase to $2.5 million from $2.2 million, while HMCA revenues rose 3.1% to $23.5 million from $22.8 million. The modest revenue gains in both segments were not enough to offset rising selling, general and administrative (SG&A) costs, which jumped 32.8% year over year to $6.8 million from $5.1 million. FONR’s operating metrics continue to underscore the centrality of HMCA to its business model. Scan volume for the quarter reached 55,106, which was 3.9% higher than the same quarter of fiscal 2025 and just slightly below the all-time high recorded in the prior quarter (55,473). Management emphasized that this represents the second-highest quarterly scan volume in HMCA’s history. Despite higher volume, cost pressures were evident across several categories, including patient fee revenue costs, management fee costs and SG&A expenses. Total costs and expenses rose 12.3% year over year to $22.8 million from $20.4 million. Investment income also declined 25.8% to $0.5 million from $0.6 million a year earlier, adding additional pressure to the bottom line. Cash and cash equivalents decreased from $56.3 million as of June 30, 2025, to $54.3 million as of Sept. 30, 2025, but the company continues to operate with a strong liquidity position, boasting a current ratio of 8.6. Fonar Corporation price-consensus-eps-surprise-chart | Fonar Corporation Quote Management highlighted continued growth in the HMCA network, which now manages 44 MR...

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Fonar Corp. (FONR) on Monday reported earnings of $2.3 million in its fiscal first quarter. The Melville, New York-based company said it had net income of 34 cents per share. The MRI scanner designer posted revenue of $26 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FONR at https://www.zacks.com/ap/FONR

Cash and cash equivalents decreased 4% to $54.3 million at September 30, 2025 as compared to the fiscal year-ended June 30, 2025. Total Revenues - Net increased by 4% to $26.0 million for the quarter ended September 30, 2025 versus the corresponding quarter one year earlier. Income from Operations decreased 30% to $3.2 million for the quarter ended September 30, 2025 versus the corresponding quarter one year earlier. Consolidated Net Income decreased 33% to $2.7 million for the quarter ended September 30, 2025 versus the corresponding quarter one year earlier. Diluted Net Income per Common Share decreased 26% to $0.34 for the quarter ended September 30, 2025 versus the corresponding quarter one year earlier. Working Capital decreased by 0.3% to $127.1 million at September 30, 2025 as compared to the fiscal year-ended June 30, 2025. On September 13, 2022, the Company adopted a stock repurchase plan of up to $9 million. At September 30, 2025, the Company has purchased over 283,770 shares at a cost of $6.1 million. Melville, New York--(Newsfile Corp. - November 10, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, reported today its financial results for the first quarter of fiscal 2026 which ended September 30, 2025. FONAR's primary source of income is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA). In 2009, HMCA managed 9 MRI scanners. Currently, HMCA manages 44 MRI scanners in New York and in Florida. Financial Results Revenues from the FONAR segment, which includes Product Sales, Upgrades, Service and Repair Fees, for related and non-related medical parties, increased 14% to $2.5 million for the quarter ended September 30, 2025, as compared to $2.2 million for the quarter ended September 30, 2024. Revenues, from the Health Management Corporation of America (HMCA) segment, increased by 3% to $23.5 million for the fiscal quarter ended September 30, 2025 as compared to $22.8 million for the fiscal quarter ended September 30, 2024. The HMCA segment manages 44 MRI scanners, consisting of patient fee revenue, (net of contractual allowances and discounts), and management and other fees for both related and non-related medical practices. Total Revenues - Net increased by 4% to $26.0 million for the 1st fiscal quarter ended September 30, 2025, as compared to $25.0 million f...

Damadian acknowledged margin pressures, citing a $2.3 million reserve tied to risk exposure from a New York-based motor vehicle insurer ordered to increase reserves due to a reported $650 million shortfall. This contributed to a $2.9 million rise in selling, general, and administrative expenses, up 10.7% year over year. The slight revenue growth was overshadowed by expense inflation and reserve-related charges. While demand for diagnostic imaging remains resilient, external factors, such as regulatory changes in Florida, have weighed on utilization and reimbursements. Higher administrative costs, particularly insurance-related reserves, further compressed profitability despite steady scan volume gains. FONAR did not provide formal financial guidance for fiscal 2026. However, management indicated plans to expand its MRI network, including the installation of another high-field MRI in Nassau County, NY, in the first half of fiscal 2026 and the opening of an additional HMCA-managed center later in the year. These moves suggest a focus on strategic network growth to support future revenue streams. FONAR’s board-approved stock repurchase plan, launched in September 2022 with authorization for up to $9 million, remained active through June 2025. To date, the company repurchased 373,942 shares for approximately $6.1 million. However, repurchases have been suspended due to the potential “take private” transaction announced in July 2025, under which the company may acquire all publicly held shares. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fonar Corporation (FONR): Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research

Cash and Cash Equivalents was $56.3 million at June 30, 2025 and the previous fiscal year. Total Revenues - Net increased 1% to $104.4 million for the fiscal year ended June 30, 2025 versus the previous fiscal year. Income from Operations decreased 30% to $11.6 million for the fiscal year ended June 30, 2025 versus the previous fiscal year. Net Income decreased 24% to $10.7 million for the fiscal year ended June 30, 2025 versus the previous fiscal year. Diluted Net Income per Common Share decreased 20% to $1.23 for the fiscal year ended June 30, 2025 versus the previous fiscal year. Working Capital increased by 4% to $127.5 million for the fiscal year ended June 30, 2025 versus the previous fiscal year. Book Value per Share for the fiscal year ended June 30, 2025 increased to $25.26 per share. On September 13, 2022, the Company adopted a stock repurchase plan of up to $9 million. Two HMCA-managed MRI scanners were added in fiscal 2025, bringing the total number to 44. A scanner was added in Melville, NY and in Naples, FL. Melville, New York--(Newsfile Corp. - September 12, 2025) - FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, today reported its Fiscal 2025 results. FONAR's primary source of income is attributable to its wholly-owned diagnostic imaging management subsidiary, Health Management Company of America (HMCA). In 2009, HMCA managed 9 MRI scanners. Currently, HMCA manages 44 MRI scanners in New York and in Florida. Financial Results Total Revenues - Net increased by 1% to $104.4 million for the fiscal year ended June 30, 2025, as compared to $102.9 million for the fiscal year ended June 30, 2024. Total Costs and Expenses for the fiscal year ended June 30, 2025 increased by 7% to $92.8 million, as compared to $86.3 million for the fiscal year ended June 30, 2024. Revenues, from the management of the diagnostic imaging center segment, consisting of Patient Fee Revenue Net of Contractual Allowances and Discounts, and Management and Other Fees of Related and Non-related Medical Practices, increased 1% to $95.4 million for the fiscal year ended June 30, 2025, as compared to $94.6 million for the fiscal year ended June 30, 2024. Revenues from Product Sales and Upgrades and Service and Repair Fees for related and non-related medical parties, were $9.0 million for the fiscal year ended June 30, 2025, as compared to $8.3 million for the fisca...

Shares of FONAR Corporation FONR have rallied 15.4% since the company released its earnings results for the fiscal third quarter ended March 31, 2025, significantly outperforming the S&P 500 Index, which gained just 0.7% during the same period. Over the past month, FONR stock has appreciated 16.9%, again outpacing the S&P 500’s 12.1% advance. For the quarter ended March 31, 2025, FONAR Corporation reported a 5.6% year-over-year increase in total net revenues, reaching $27.2 million from $25.7 million in the prior-year period. Net income attributable to the company climbed 25.8% to $3.1 million from $2.5 million a year earlier despite a 2.2% decline in income from operations to $3.66 million from $3.75 million. FONR’s diluted net income per common share available to stockholders surged 37% to $0.37, up from $0.27 in the third quarter of fiscal 2024. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Segmentally, FONAR Corporation generated $12.9 million in management and other fees, a 6.4% increase over the year-ago figure of $12.1 million. Service and repair fees rose 26.2% year over year to $2.3 million from the year-ago figure of $1.8 million, while patient fee revenues increased 2.8% to $8.9 million from $8.6 million. However, product sales dropped 50% to $55,000 from $110,000 in the comparable period last year. FONAR Corporation maintained tight control over its expenses, although total costs and expenses increased 6.9% to $23.5 million from $21.9 million. Selling, general and administrative (SG&A) expenses rose 5.2% to $7.9 million from $7.6 million. Despite these increases, FONR reported a solid net margin improvement due to its revenue growth and a significantly lower tax provision of $1 million, down from $1.8 million in the prior year. The balance sheet remained healthy, with total assets edging up slightly to $214.9 million as of March 31, 2025 from $214.2 million as of June 30, 2024, and total liabilities declining to $54.7 million from $57.5 million. FONAR Corporation’s current ratio improved to 10.0 as of March 31, 2025, up from 7.9 as of June 30, 2024, indicating robust short-term liquidity. Working capital also increased 4% to $127.1 million as of March 31, 2025 from $122.5 million as of June 30, 2024, and net book value per common share rose 5% to $25.98 as of March 31, 2025 from $24.78 per share March 31, 2024. Operati...

Revenue: US$27.2m (up 5.6% from 3Q 2024). Net income: US$2.39m (up 34% from 3Q 2024). Profit margin: 8.8% (up from 6.9% in 3Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.38 (up from US$0.28 in 3Q 2024). Our free stock report includes 1 warning sign investors should be aware of before investing in FONAR. Read for free now. All figures shown in the chart above are for the trailing 12 month (TTM) period FONAR shares are up 4.3% from a week ago. What about risks? Every company has them, and we've spotted 1 warning sign for FONAR you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MELVILLE, N.Y. (AP) — MELVILLE, N.Y. (AP) — Fonar Corp. (FONR) on Thursday reported profit of $2.5 million in its fiscal third quarter. The Melville, New York-based company said it had profit of 37 cents per share. The MRI scanner designer posted revenue of $27.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FONR at https://www.zacks.com/ap/FONR